How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Contract Pharmaceutical Packaging Market
- By Packaging Type: Blister Packaging, Bottle Packaging, Strip Packaging, Vial Packaging, Ampoule Packaging, Sachet Packaging
- By Packaging Material: Plastic Packaging, Glass Packaging, Aluminum Packaging, Paperboard Packaging, Composite Packaging
- By Dosage Form: Solid Dosage Forms, Liquid Dosage Forms, Semi-solid Dosage Forms, Injectables, Inhalers
- By Service Type: Primary Packaging, Secondary Packaging, Labeling and Serialization, Assembly and Kitting, Packaging Design and Development
- By End User: Pharmaceutical Companies, Biotechnology Companies, Generic Drug Manufacturers, Nutraceutical Companies, Veterinary Pharmaceutical Companies
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Blister Packaging leads By Packaging Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 308 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.187 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.195 →
Full report · locked preview
Everything inside the Contract Pharmaceutical Packaging Market report
A complete, evidence-based study - 12 chapters and 129 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Packaging Type 6
Packaging Material 5
Dosage Form 5
Service Type 5
End User 5
Companies profiled
Catalent Inc.
PCI Pharma Services
Sharp Packaging Services
Bormioli Pharma
Famar
Recipharm AB
Vetter Pharma International GmbH
Aenova Group
Baxter International Inc.
Lonza Group AG
Siegfried Holding AG
Cambrex Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Catalent Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →PCI Pharma Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sharp Packaging Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Bormioli Pharma
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Famar
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Recipharm AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Vetter Pharma International GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Aenova Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Baxter International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Lonza Group AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Siegfried Holding AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Cambrex Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Almac Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Thermo Fisher Scientific Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Patheon (a part of Thermo Fisher Scientific)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,130M by 2033 · 7.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Blister Packaging50.6
- Bottle Packaging8.0
- Strip Packaging8.1
- Vial Packaging5.8
- Ampoule Packaging15.6
- Sachet Packaging12.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,127M → $2,075M · 7.9%
Europe$785.2M → $1,557M · 8.9%
Asia Pacific$716.9M → $1,302M · 7.7%
Latin America$443.8M → $754.2M · 6.9%
Middle East and Africa$341.4M → $669.3M · 8.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.552026
7.562027
7.562028
7.582029
7.592030
7.612031
7.622032
7.622033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Catalent Inc.19.7
- PCI Pharma Services23.3
- Sharp Packaging Services7.1
- Bormioli Pharma6.9
- Famar7.0
- Recipharm AB8.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Packaging Type26.7%
Packaging Material18.6%
Dosage Form21.3%
Service Type13.4%
End User19.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.6
- Europe24.5
- Asia Pacific20.5
- Latin America11.9
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 92 | 78 | 81 | 94 | 85 | 95 | 88 |
| PCI Pharma Services | 74 | 76 | 82 | 71 | 74 | 83 | 77 |
| Sharp Packaging Services | 64 | 71 | 83 | 66 | 76 | 85 | 74 |
| Bormioli Pharma | 73 | 61 | 80 | 82 | 72 | 80 | 75 |
| Famar | 74 | 57 | 62 | 55 | 54 | 72 | 62 |
| Recipharm AB | 69 | 60 | 47 | 56 | 62 | 47 | 57 |
| Vetter Pharma International GmbH | 65 | 43 | 43 | 52 | 52 | 41 | 49 |
| Aenova Group | 55 | 38 | 53 | 40 | 53 | 55 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Catalent Inc.
- PCI Pharma Services
- Sharp Packaging Services
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Catalent Inc. | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| PCI Pharma Services | ◐ | ◐ | ✓ | − | ◐ | ✓ |
| Sharp Packaging Services | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Bormioli Pharma | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Famar | − | − | ◐ | − | − | ✓ |
| Recipharm AB | ◐ | − | − | ◐ | − | − |
| Vetter Pharma International GmbH | − | − | − | − | − | − |
| Aenova Group | ◐ | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Catalent Inc.88
2PCI Pharma Services77
3Bormioli Pharma75
4Sharp Packaging Services74
5Famar62
6Recipharm AB57
7Vetter Pharma International GmbH49
8Aenova Group49
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Catalent Inc.
Challenger3
Strong scale, closing on the leaders.
PCI Pharma ServicesSharp Packaging ServicesBormioli Pharma
Contender2
Focused players with pockets of strength.
FamarRecipharm AB
Niche2
Specialists in a single segment or region.
Vetter Pharma International GmbHAenova Group
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Packaging Type in North America, then scale across Contract Pharmaceutical Packaging Market — a $247M beachhead inside a $3.65B market.
Beachhead (SOM)$247Mobtainable near-term
Serviceable (SAM)$1.49Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Blister Packaging
Best fit — highest urgency & budget in Packaging Type.
Economic buyer79 fit
Bottle Packaging
Strong fit — clear ROI and a fast path to value.
End user69 fit
Strip Packaging
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Packaging Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Packaging Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Dosage Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel29%
Digital / self-serve18%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Packaging Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Contract Pharmaceutical Packaging Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified26%
Evaluation14%
Closed-won6%
$8.5KCAC
$29KLTV
3.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Contract Pharmaceutical Packaging Market is a resilient opportunity — $4.03B by 2033, compounding at 4.0%.
TAM · 2025$2.94Btoday
TAM · 2033$4.03Bforecast
CAGR4.0%2027–2033
Cumulative$31.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.03BTotal addressable market
SAM$1.68BServiceable available market
SOM$332MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.0% CAGR
Demand compounds through 2033, outpacing GDP across Packaging Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Packaging Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.03BLarge & growingTAM by 2033 at 4.0% CAGR
$1.68BServiceable nowreachable with today’s model
$332MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.15BBear2.6% CAGR
$4.03BBase4.0% CAGR
$5.16BBull5.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Packaging Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Contract Pharmaceutical Packaging Market — a $5.28B market by 2033. Plan: grow share from 7.6% to 16.5%.
Market size · 2033$5.28Btotal addressable
Market CAGR10.7%2027–2033
Target share16.5%from 7.6% today
Revenue ambition$872Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.6% | 16.5% | On track |
| Revenue | $379M | $872M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.8% | 45.4% | Behind |
| Customer retention | 84.7% | 96.4% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Packaging Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Packaging Material capability
A defensible second engine — invest in Packaging Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Packaging Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Packaging Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $111M capacity & capability investment
- Greenlight bolt-on M&A in Packaging Material
- Authorise North America expansion plan
- Fund R&D program for Packaging Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Contract Pharmaceutical Packaging Market conversation — a $7.50B market you can size, segment and defend in minutes.
Market size · 2033$7.50Btotal opportunity
Growth8.5%CAGR to 2033
Addressable buyers1,196+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Packaging Type
Goal Grow share in Packaging Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 2 mopayback period
$69K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Catalent Inc.PCI Pharma ServicesSharp Packaging ServicesBormioli PharmaFamarRecipharm ABVetter Pharma International GmbHAenova Group+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Contract Pharmaceutical Packaging Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Contract Pharmaceutical Packaging Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Contract Research Organizations (CROs) Services Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportContract Textile Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportContrast Agents for MRI Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportContrast Catheter Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportContrast Injector in Vascular Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportContrast Media and Contrast Agents Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportContrast Media and Medical Devices Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportContrast Media Injectors (Cmi) Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportContrast Media or Contrast Agent Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportContrast Media Radiology Products Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportContrast Sensors Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportControl & Instrumentation Cables Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.